B of A Securities Initiates Coverage On Sutro Biopharma With Buy Rating, Announces Price Target of $12
B of A Securities Initiates Coverage On Sutro Biopharma With Buy Rating, Announces Price Target of $12
B of A Securities以買入評級啓動對Sutro Biopharma的報道，宣佈目標股價爲12美元
B of A Securities analyst Tazeen Ahmad initiates coverage on Sutro Biopharma (NASDAQ:STRO) with a Buy rating and announces Price Target of $12.
B of A Securities分析師塔澤恩·艾哈邁德以買入評級啓動了對Sutro Biopharma（納斯達克股票代碼：STRO）的報道，並宣佈目標股價爲12美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。